一个MDM2和MDMX的双特异性d-抗体,用于抗瘤免疫疗法
Chongbing Liao1,2,3, Jin Yan4, William D Tolbert5
1Department of Clinical Pharmacology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Journal of medicinal chemistry
|August 18, 2025
概括
研究人员设计了一种代谢稳定的,D-PMI-omega,以破坏促进癌症的蛋白质相互作用. 这种会重新激活p53通路,抑制黑色素瘤的生长,并提高免疫治疗的疗效.
科学领域:
- 在瘤学瘤学.
- 体设计 体设计
- 免疫治疗是一种免疫疗法.
背景情况:
- 针对p53-MDM2/MDMX相互作用是一种有前途的抗癌策略.
- 代谢稳定的提供了一种新的治疗方法.
- 传统的药物发现在针对这些相互作用方面面临挑战.
研究的目的:
- 设计一种针对p53-MDM2/MDMX复合体的蛋白质分解耐药.
- 为了评估的有效性在体外和体内.
- 评估的潜力与免疫疗法结合使用.
主要方法:
- 一个d-dodecapeptide (D-PMI-omega) 的设计和合成.
- 在金纳米颗粒上制造.
- 在体外和体内实验,包括细胞培养,瘤外移植和免疫疗法组合研究.
主要成果:
- D-PMI-omega 干扰了 p53-MDM2/MDMX 复合体的发生.
- 该有效地进入瘤细胞并通过重新激活p53.3诱导细胞死亡.
- 在体内,D-PMI-omega通过调节T细胞群来抑制黑色素瘤的生长,并强化了抗PD1免疫疗法.
结论:
- D-PMI-omega是一种治疗上可行的抗癌.
- 这种酸在耐药瘤中显示出组合治疗的潜力.
- 这种方法验证了用于增强免疫治疗的设计.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K


